TB-500: Uses, Dosage Ranges, Safety & Legal Status (2026)
TB-500 is a synthetic peptide based on the active region of thymosin beta-4, studied in animals for muscle, tendon, and wound healing and for flexibility. It is not approved for human use, is banned in sport, and is sold only as a "research chemical." Doses commonly reported in the community run around 2–2.5 mg per injection, often twice weekly during a loading phase and then weekly — but there is no clinically established safe human dose, and long-term effects are unknown.
Editorially reviewed · Last updated June 2026 · This article is educational and is not medical advice. Talk to a licensed clinician before using any peptide.
What is TB-500?
TB-500 is a lab-made peptide modeled on the active fragment of thymosin beta-4 (Tβ4), a naturally occurring protein found in nearly all human and animal cells and present in high amounts at wound sites. Tβ4 itself is a 43–amino-acid protein; TB-500 is the shorter synthetic version sold to reproduce its repair-related activity.
Its studied mechanisms center on actin regulation (helping cells migrate and rebuild tissue), angiogenesis (new blood-vessel growth), and reduced inflammation. In animal models that translates to faster healing of muscle, tendon, ligament, skin, and even cardiac tissue.
The honest summary: the animal and cell research is real and Tβ4 has been investigated clinically for wound and eye conditions, but TB-500 as sold has no large, completed, published human trials proving it works or is safe at any dose for the recovery uses people buy it for.
What people use TB-500 for
People most commonly report using TB-500 for:
- Tendon, ligament, and muscle injury recovery
- Joint mobility and flexibility
- Chronic or stubborn soft-tissue injuries
- General recovery, often stacked with BPC-157 (the two are frequently paired)
As with BPC-157, separate reported use from proven use. The recovery claims rest on animal research and anecdote, not human trials. Anyone presenting TB-500 as an established injury treatment is overstating the evidence.
TB-500 dosage: commonly reported ranges
The figures below are commonly reported in community use and extrapolated from animal research. They are not a recommendation, a protocol, or a verified safe dose. Dosing varies widely because there's no human standard, body weight and goals differ, and product purity is inconsistent across sources.
| Phase | Commonly reported range | Notes |
|---|---|---|
| Loading phase | ~2–2.5 mg per injection, ~2× per week | Typically run for ~4–6 weeks |
| Maintenance phase | ~2–2.5 mg, once weekly or every 1–2 weeks | After loading; reflects the long tissue residence |
| Weekly total (loading) | ~4–5 mg | Sum of the loading doses |
| Route | Subcutaneous (sometimes intramuscular) | SC is the most commonly described |
| Typical reported cycle | ~4–6 weeks loading, then taper/maintain or stop | Often cycled off afterward |
Why the weekly (rather than daily) cadence: Tβ4-based peptides are reported to have a relatively long duration of action in tissue, so people inject far less frequently than something like BPC-157. Two plain-language cautions:
- There's no human dose-response data to anchor any of these numbers.
- The dose is only as accurate as the source. Underdosed, overdosed, and contaminated "research chemical" vials are common — see sourcing below.
How TB-500 is reconstituted
Injectable TB-500 ships as a freeze-dried powder mixed with bacteriostatic water before use. The number of "units" you draw on an insulin syringe depends entirely on how much water you add to the vial, which is where most dosing errors happen. Use our peptide calculator to check draw volumes against your syringe size and to catch unit mistakes (mg versus mcg).
People who use it typically refrigerate the reconstituted vial, keep it out of light, and use sterile technique. If you can't reconstitute and measure accurately and sterilely, that alone is a reason not to inject. For more compounds and routes, see the peptide dosing protocols hub.
TB-500 side effects and safety
With no large human safety studies, the honest answer to "is it safe?" is we don't know. What's reported:
- Anecdotally reported, usually mild:fatigue or a brief "head-rush"/lightheadedness after dosing, temporary lethargy, injection-site irritation, headache, nausea.
- The major open question — cancer risk.Like BPC-157, TB-500 promotes blood-vessel growth and cell migration, and tumors rely on those same processes. There's a theoretical concern it could promote existing or undiagnosed cancers. Unproven either way, but it's why people with a personal or family cancer history are widely advised to avoid it.
- Unknown long-term effects. No good data on months or years of use.
- Contamination and dosing risk from unregulated sourcing — arguably the most realistic near-term danger.
Stop and seek medical care for signs of injection-site infection (spreading redness, heat, pus, fever), chest pain, severe allergic reaction, or any unusual lump or growth.
Is TB-500 legal in 2026?
TB-500 sits in the same gray zone as other research peptides, and its status is actively in motion:
- It is not approved by the FDA for any human use.
- It is sold only as a "Research Use Only" / "research chemical, not for human consumption" product — a liability shield for the seller, not a safety clearance.
- It is banned in sport. Thymosin beta-4 / TB-500 is on the World Anti-Doping Agency Prohibited List (class S0, non-approved substances); tested athletes and military service members should treat it as a guaranteed violation.
- This may change soon: the FDA's Pharmacy Compounding Advisory Committee is scheduled to review TB-500 (free base and acetate forms) on July 23–24, 2026, as a bulk drug substance being considered for the 503A Bulks List. The outcome could move TB-500 toward or further away from legal compounding.
For most individuals, possession isn't separately criminalized, but selling it for human use draws FDA enforcement, and using it makes you personally responsible for an unapproved, untested product.
How to evaluate TB-500 sourcing and quality
If someone is going to use it despite the above, sourcing is where the most avoidable harm lives:
- A recent, batch-specific Certificate of Analysis (COA) with HPLC purity (ideally ≥98%) and mass-spec identity confirmation.
- Independent third-party testing, not just the vendor's in-house lab.
- Sterile, properly sealed vials and clear storage guidance.
- Realistic claims — any vendor calling it "FDA-approved" or a guaranteed injury cure is lying.
No COA, vague sourcing, or suspiciously low pricing are all reasons to walk away.
Who should not use TB-500
- Anyone pregnant or breastfeeding
- Anyone with a personal or family history of cancer (angiogenesis / cell-migration concern)
- Competitive or tested athletes and service members (WADA-banned)
- Anyone who can't get clinical oversight or verify their source
- Minors
References
- FDA — Pharmacy Compounding Advisory Committee meeting, July 23–24, 2026 (503A Bulks List review)
- World Anti-Doping Agency — Prohibited List (S0, non-approved substances)
- DoD Operation Supplement Safety (OPSS) — peptide advisories
- Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med (2012)
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol (1999)
- RegeneRx Biopharmaceuticals — thymosin beta-4 clinical development (RGN-259 dry eye, wound repair programs)
← All dosing protocolsResourcesPeptide calculatorEU shop rankings
Frequently asked questions
What is a typical TB-500 dosage?
Commonly reported ranges are roughly 2–2.5 mg per injection, often twice weekly during a 4–6 week loading phase, then weekly or every other week. This reflects community use and animal-study extrapolation, not a clinically validated or recommended human dose.
Is TB-500 safe?
There's no large human safety data, so it can't honestly be called safe. Reported side effects are usually mild (fatigue, head-rush, injection-site irritation), but long-term effects are unknown and there's a theoretical tumor-growth concern.
Is TB-500 legal in 2026?
It's not FDA-approved and is sold only as a "research chemical." The FDA is reviewing it for the 503A compounding list in July 2026, so its status may change.
Is TB-500 banned in sport?
Yes. Thymosin beta-4 / TB-500 is on WADA's Prohibited List (S0). Tested athletes and service members should not use it.
What's the difference between TB-500 and BPC-157?
Both are recovery peptides often stacked together. TB-500 is based on thymosin beta-4 and dosed weekly in milligrams; BPC-157 is gastric-derived and dosed daily in micrograms. Neither has strong human safety data.
Why is TB-500 dosed weekly instead of daily?
It's reported to have a long duration of action in tissue, so people inject far less frequently than peptides like BPC-157. Note this cadence comes from community practice, not established human pharmacokinetics.
How should TB-500 be stored?
Lyophilized powder is kept cold and out of light; once reconstituted with bacteriostatic water it's refrigerated and used within a limited window. Follow the source's batch-specific guidance.